Published in J Cell Biol on June 14, 1999
Chemically diverse toxicants converge on Fyn and c-Cbl to disrupt precursor cell function. PLoS Biol (2007) 1.92
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain (2009) 1.49
Integrins direct Src family kinases to regulate distinct phases of oligodendrocyte development. J Cell Biol (2004) 1.47
Assembly of myelin by association of proteolipid protein with cholesterol- and galactosylceramide-rich membrane domains. J Cell Biol (2000) 1.47
Activation of oligodendroglial Fyn kinase enhances translation of mRNAs transported in hnRNP A2-dependent RNA granules. J Cell Biol (2008) 1.44
Identification of a novel oligodendrocyte cell adhesion protein using gene expression profiling. J Neurosci (2006) 1.32
Inhibition of myelin membrane sheath formation by oligodendrocyte-derived exosome-like vesicles. J Biol Chem (2010) 1.29
Overexpression of the myelin proteolipid protein leads to accumulation of cholesterol and proteolipid protein in endosomes/lysosomes: implications for Pelizaeus-Merzbacher disease. J Cell Biol (2002) 1.27
Tyrosine phosphorylation of QKI mediates developmental signals to regulate mRNA metabolism. EMBO J (2003) 1.17
p190RhoGAP can act to inhibit PDGF-induced gliomas in mice: a putative tumor suppressor encoded on human chromosome 19q13.3. Genes Dev (2003) 1.16
Quantitative analysis of the detergent-insoluble brain proteome in frontotemporal lobar degeneration using SILAC internal standards. J Proteome Res (2012) 1.05
Regulation of cross-linked actin network (CLAN) formation in human trabecular meshwork (HTM) cells by convergence of distinct beta1 and beta3 integrin pathways. Invest Ophthalmol Vis Sci (2009) 1.05
Laminin alters fyn regulatory mechanisms and promotes oligodendrocyte development. J Neurosci (2009) 1.04
Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia (2008) 1.02
Heterogeneous nuclear ribonucleoprotein (hnRNP) F is a novel component of oligodendroglial RNA transport granules contributing to regulation of myelin basic protein (MBP) synthesis. J Biol Chem (2011) 1.00
Focal adhesion kinase (FAK): A regulator of CNS myelination. J Neurosci Res (2009) 1.00
CaMKIIβ regulates oligodendrocyte maturation and CNS myelination. J Neurosci (2013) 1.00
Src family kinases are required for prolactin induction of cell proliferation. Mol Biol Cell (2001) 0.99
Protein-tyrosine phosphatase alpha acts as an upstream regulator of Fyn signaling to promote oligodendrocyte differentiation and myelination. J Biol Chem (2009) 0.99
Proteomic identification of novel targets regulated by the mammalian target of rapamycin pathway during oligodendrocyte differentiation. Glia (2011) 0.98
Phosphodiesterase-Ialpha/autotaxin's MORFO domain regulates oligodendroglial process network formation and focal adhesion organization. Mol Cell Neurosci (2007) 0.97
Myelin management by the 18.5-kDa and 21.5-kDa classic myelin basic protein isoforms. J Neurochem (2013) 0.96
Myosin II is a negative regulator of oligodendrocyte morphological differentiation. J Neurosci Res (2012) 0.93
Phosphorylation and lipid raft association of fibroblast growth factor receptor-2 in oligodendrocytes. Glia (2009) 0.93
Modulation of oligodendrocyte differentiation and maturation by combined biochemical and mechanical cues. Sci Rep (2016) 0.92
Essential function, sophisticated regulation and pathological impact of the selective RNA-binding protein QKI in CNS myelin development. Future Neurol (2008) 0.92
Axon-glia interaction and membrane traffic in myelin formation. Front Cell Neurosci (2014) 0.90
Proline substitutions and threonine pseudophosphorylation of the SH3 ligand of 18.5-kDa myelin basic protein decrease its affinity for the Fyn-SH3 domain and alter process development and protein localization in oligodendrocytes. J Neurosci Res (2011) 0.89
Regulatory mechanisms that mediate tenascin C-dependent inhibition of oligodendrocyte precursor differentiation. J Neurosci (2010) 0.88
Myelin associated glycoprotein cross-linking triggers its partitioning into lipid rafts, specific signaling events and cytoskeletal rearrangements in oligodendrocytes. Neuron Glia Biol (2004) 0.87
Integrin signaling in oligodendrocytes and its importance in CNS myelination. J Signal Transduct (2010) 0.87
Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes. J Neurochem (2010) 0.87
Neonatal and adult O4(+) oligodendrocyte lineage cells display different growth factor responses and different gene expression patterns. J Neurosci Res (2009) 0.86
Guiding stem cell differentiation into oligodendrocytes using graphene-nanofiber hybrid scaffolds. Adv Mater (2014) 0.85
Oligodendrocyte-specific expression of human immunodeficiency virus type 1 Nef in transgenic mice leads to vacuolar myelopathy and alters oligodendrocyte phenotype in vitro. J Virol (2003) 0.85
Slit2 regulates the dispersal of oligodendrocyte precursor cells via Fyn/RhoA signaling. J Biol Chem (2012) 0.84
Signaling mechanisms regulating myelination in the central nervous system. Neurosci Bull (2013) 0.83
Differential effects of Th1, monocyte/macrophage and Th2 cytokine mixtures on early gene expression for molecules associated with metabolism, signaling and regulation in central nervous system mixed glial cell cultures. J Neuroinflammation (2009) 0.83
Distinct roles for N-Cadherin linked c-Src and fyn kinases in lens development. Dev Dyn (2013) 0.83
p39, the primary activator for cyclin-dependent kinase 5 (Cdk5) in oligodendroglia, is essential for oligodendroglia differentiation and myelin repair. J Biol Chem (2013) 0.82
Fyn regulates adipogenesis by promoting PIKE-A/STAT5a interaction. Mol Cell Biol (2013) 0.81
Loss of protein-tyrosine phosphatase α (PTPα) increases proliferation and delays maturation of oligodendrocyte progenitor cells. J Biol Chem (2012) 0.80
Variable sensitivity to complement-dependent cytotoxicity in murine models of neuromyelitis optica. J Neuroinflammation (2016) 0.79
Altered gene expression in the adult brain of fyn-deficient mice. Cell Mol Neurobiol (2004) 0.78
Oligodendroglial p130Cas is a target of Fyn kinase involved in process formation, cell migration and survival. PLoS One (2014) 0.78
The Autotaxin-Lysophosphatidic Acid Axis Modulates Histone Acetylation and Gene Expression during Oligodendrocyte Differentiation. J Neurosci (2015) 0.78
Modulation of Oligodendrocyte Differentiation by Mechanotransduction. Front Cell Neurosci (2016) 0.77
Modulation of Rho-Rock signaling pathway protects oligodendrocytes against cytokine toxicity via PPAR-α-dependent mechanism. Glia (2013) 0.77
An anti-sulfatide antibody O4 immunoprecipitates sulfatide rafts including Fyn, Lyn and the G protein α subunit in rat primary immature oligodendrocytes. Glycoconj J (2013) 0.76
Hierarchical CRMP2 posttranslational modifications control NaV1.7 function. Proc Natl Acad Sci U S A (2016) 0.75
Abnormal myelination in the spinal cord of PTPα-knockout mice. Cell Adh Migr (2013) 0.75
Mechanical Strain Promotes Oligodendrocyte Differentiation by Global Changes of Gene Expression. Front Cell Neurosci (2017) 0.75
Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol (1997) 11.36
Discovery of a novel, potent, and Src family-selective tyrosine kinase inhibitor. Study of Lck- and FynT-dependent T cell activation. J Biol Chem (1996) 10.08
pp59fyn mutant mice display differential signaling in thymocytes and peripheral T cells. Cell (1992) 3.70
Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol (1981) 3.35
Platelet-derived growth factor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/type-2 astrocyte progenitor cell. Nature (1988) 2.99
The oligodendrocyte and its many cellular processes. Trends Cell Biol (1993) 2.91
c-Src enhances the spreading of src-/- fibroblasts on fibronectin by a kinase-independent mechanism. Genes Dev (1995) 2.72
Multiple extracellular signals are required for long-term oligodendrocyte survival. Development (1993) 2.55
The Src family tyrosine kinases are required for platelet-derived growth factor-mediated signal transduction in NIH 3T3 cells. Proc Natl Acad Sci U S A (1993) 2.41
Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. Genes Dev (1994) 2.28
Early changes in the distribution and organization of microfilament proteins during cell transformation. Cell (1981) 2.25
Initial events of myelination involve Fyn tyrosine kinase signalling. Nature (1994) 2.08
Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci (1998) 2.06
Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05
Negative regulation of T-cell receptor signalling by tyrosine protein kinase p50csk. Nature (1993) 2.05
Down-regulation of the filamentous actin cross-linking activity of cortactin by Src-mediated tyrosine phosphorylation. J Biol Chem (1997) 2.04
Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type-2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A (1990) 1.89
Signal transduction by nerve growth factor and fibroblast growth factor in PC12 cells requires a sequence of src and ras actions. J Cell Biol (1991) 1.82
Accumulation of the cyclin-dependent kinase inhibitor p27/Kip1 and the timing of oligodendrocyte differentiation. EMBO J (1997) 1.77
FGF modulates the PDGF-driven pathway of oligodendrocyte development. Neuron (1990) 1.72
Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol Biol Cell (1997) 1.59
The migrational patterns and developmental fates of glial precursors in the rat subventricular zone are temporally regulated. Development (1993) 1.58
Association of Fyn with the activated platelet-derived growth factor receptor: requirements for binding and phosphorylation. Oncogene (1992) 1.46
pp60c-src is a positive regulator of growth factor-induced cell scattering in a rat bladder carcinoma cell line. J Cell Biol (1995) 1.37
Demyelinating diseases--new pathological insights, new therapeutic targets. N Engl J Med (1998) 1.37
A role in migration for the alpha V beta 1 integrin expressed on oligodendrocyte precursors. J Neurosci (1996) 1.25
Specific expressions of Fyn and Lyn, lymphocyte antigen receptor-associated tyrosine kinases, in the central nervous system. Brain Res Mol Brain Res (1992) 1.12
Expression of alpha vbeta3 and alpha vbeta8 integrins during oligodendrocyte precursor differentiation in the presence and absence of axons. Glia (1997) 1.12
Genetic evidence for a tyrosine kinase cascade preceding the mitogen-activated protein kinase cascade in vertebrate G protein signaling. J Biol Chem (1997) 1.07
Fibroblast growth factor receptor-1 regulation of Src family kinases. Oncogene (1995) 1.01
Antibody to galactocerebroside alters organization of oligodendroglial membrane sheets in culture. J Neurosci (1988) 1.00
p59fyn in rat brain is localized in developing axonal tracts and subpopulations of adult neurons and glia. Oncogene (1993) 1.00
Transplanted oligodendrocyte progenitor cells expressing a dominant-negative FGF receptor transgene fail to migrate in vivo. J Neurosci (1997) 0.99
Axon-glia interactions: building a smart nerve fiber. Curr Biol (1997) 0.97
Effects of acidic and basic fibroblast growth factors on proliferation and maturation of cultured rat oligodendrocytes. Int J Dev Neurosci (1989) 0.91
Nerve-growth-factor-treated and v-src-expressing PC 12 cells: a model for neuronal differentiation. Biochem Soc Trans (1991) 0.80
Glial cell lineage and development. Curr Opin Neurobiol (1994) 0.80
Identification of a membrane-binding domain within the amino-terminal region of human immunodeficiency virus type 1 Gag protein which interacts with acidic phospholipids. J Virol (1994) 6.67
Bradykinin and nerve growth factor release the capsaicin receptor from PtdIns(4,5)P2-mediated inhibition. Nature (2001) 6.26
Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature (1992) 4.46
High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature (1991) 4.44
Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Mol Cell Biol (2001) 4.09
Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell (1992) 3.91
The trk proto-oncogene product: a signal transducing receptor for nerve growth factor. Science (1991) 3.86
Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene. Cell (1987) 3.60
Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol (2000) 3.54
Differential membrane binding of the human immunodeficiency virus type 1 matrix protein. J Virol (1996) 3.19
Inhibition of protein palmitoylation, raft localization, and T cell signaling by 2-bromopalmitate and polyunsaturated fatty acids. J Biol Chem (2000) 3.18
Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomains. J Virol (2001) 2.82
The regulated expression of beta-globin genes introduced into mouse erythroleukemia cells. Cell (1983) 2.75
The Concise Guide to PHARMACOLOGY 2013/14: overview. Br J Pharmacol (2013) 2.48
Highly specific antibody to Rous sarcoma virus src gene product recognizes a novel population of pp60v-src and pp60c-src molecules. J Cell Biol (1985) 2.32
Vanadate inhibits the red cell (Na+, K+) ATPase from the cytoplasmic side. Nature (1978) 2.27
Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature (1996) 2.14
Amino-terminal basic residues of Src mediate membrane binding through electrostatic interaction with acidic phospholipids. Proc Natl Acad Sci U S A (1994) 2.12
Kinetic analysis of human immunodeficiency virus type 1 assembly reveals the presence of sequential intermediates. J Virol (2000) 2.11
Competitive signaling between TrkA and p75 nerve growth factor receptors determines cell survival. J Neurosci (1998) 2.06
Oligodendrocyte precursor differentiation is perturbed in the absence of the cyclin-dependent kinase inhibitor p27Kip1. Genes Dev (1997) 2.05
Rapid plasma membrane anchoring of newly synthesized p59fyn: selective requirement for NH2-terminal myristoylation and palmitoylation at cysteine-3. J Cell Biol (1997) 2.03
K-252a inhibits nerve growth factor-induced trk proto-oncogene tyrosine phosphorylation and kinase activity. J Biol Chem (1992) 2.01
Membrane binding of myristylated peptides corresponding to the NH2 terminus of Src. Biochemistry (1994) 1.99
Gene transfer and molecular cloning of the human NGF receptor. Science (1986) 1.91
Dual myristylation and palmitylation of Src family member p59fyn affects subcellular localization. J Biol Chem (1994) 1.90
Activation of Trk neurotrophin receptors in the absence of neurotrophins. Proc Natl Acad Sci U S A (2001) 1.85
Nerve growth factor stimulates a protein kinase in PC-12 cells that phosphorylates microtubule-associated protein-2. J Biol Chem (1990) 1.82
Biochemical characterization of a palmitoyl acyltransferase activity that palmitoylates myristoylated proteins. J Biol Chem (1995) 1.79
Electrostatics and the membrane association of Src: theory and experiment. Biochemistry (1998) 1.78
In vitro synthesis of pp60v-src: myristylation in a cell-free system. Mol Cell Biol (1988) 1.77
Molecular cloning and characterization of an antigen associated with early stages of melanoma tumor progression. Cancer Res (1988) 1.72
Activation of the sphingomyelin cycle through the low-affinity neurotrophin receptor. Science (1994) 1.71
Evidence for a second function of the MA sequence in the Rous sarcoma virus Gag protein. J Virol (1996) 1.70
DNA sequence directs placement of histone cores on restriction fragments during nucleosome formation. Biochemistry (1979) 1.69
GIPC and GAIP form a complex with TrkA: a putative link between G protein and receptor tyrosine kinase pathways. Mol Biol Cell (2001) 1.65
Heterogeneous fatty acylation of Src family kinases with polyunsaturated fatty acids regulates raft localization and signal transduction. J Biol Chem (2001) 1.63
Human immunodeficiency virus type 1 protease triggers a myristoyl switch that modulates membrane binding of Pr55(gag) and p17MA. J Virol (1999) 1.62
Metastatic and histologic presentations in unknown primary cancer. Semin Oncol (1977) 1.61
Palmitoylation of p59fyn is reversible and sufficient for plasma membrane association. Mol Biol Cell (1997) 1.59
The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations. J Clin Invest (1999) 1.58
Identifying the primary site in metastatic cancer of unknown origin. Inadequacy of roentgenographic procedures. JAMA (1979) 1.57
Association of the p75 neurotrophin receptor with TRAF6. J Biol Chem (1999) 1.56
Association of Trk neurotrophin receptors with components of the cytoplasmic dynein motor. J Neurosci (2001) 1.53
Lysine residues form an integral component of a novel NH2-terminal membrane targeting motif for myristylated pp60v-src. J Cell Biol (1992) 1.53
Access to data and the information explosion: oral contraceptives and risk of cancer. Contraception (1981) 1.52
Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci U S A (1993) 1.51
p80/85 cortactin associates with the Src SH2 domain and colocalizes with v-Src in transformed cells. J Biol Chem (1995) 1.48
Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem (1998) 1.48
High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem (1994) 1.48
The trk proto-oncogene rescues NGF responsiveness in mutant NGF-nonresponsive PC12 cell lines. Cell (1991) 1.47
An evolutionarily conserved transmembrane protein that is a novel downstream target of neurotrophin and ephrin receptors. J Neurosci (2001) 1.33
The structure of the thymidine kinase gene promoter: nuclease hypersensitivity correlates with expression. Cell (1982) 1.30
Mesenchymal and neuronal cell expression of the p75 neurotrophin receptor gene occur by different mechanisms. Dev Biol (1995) 1.28
p75LNGFR regulates Trk signal transduction and NGF-induced neuronal differentiation in MAH cells. Neuron (1994) 1.28
The cytoplasmic and transmembrane domains of the p75 and Trk A receptors regulate high affinity binding to nerve growth factor. J Biol Chem (2001) 1.25
Expression of functional nerve growth factor receptors after gene transfer. Science (1989) 1.25
Development of a patient satisfaction scale. Res Nurs Health (1986) 1.24
Loss of p27Kip1 function results in increased proliferative capacity of oligodendrocyte progenitors but unaltered timing of differentiation. Development (1999) 1.23
Iodinated fatty acids as probes for myristate processing and function. Incorporation into pp60v-src. J Biol Chem (1993) 1.22
p21cip1 is required for the differentiation of oligodendrocytes independently of cell cycle withdrawal. EMBO Rep (2001) 1.20
Brain-specific src oncogene mRNA mapped in rat brain by in situ hybridization. Proc Natl Acad Sci U S A (1988) 1.17
A novel interaction between the juxtamembrane region of the p55 tumor necrosis factor receptor and phosphatidylinositol-4-phosphate 5-kinase. J Biol Chem (1997) 1.17
Dual fatty acylation of p59(Fyn) is required for association with the T cell receptor zeta chain through phosphotyrosine-Src homology domain-2 interactions. J Cell Biol (1999) 1.16
Synthesis and use of iodo-fatty acid analogs. Methods Enzymol (1995) 1.16
Tyrosine phosphorylation of p190 RhoGAP by Fyn regulates oligodendrocyte differentiation. J Neurobiol (2001) 1.16
Effectiveness of a simulator in training anesthesiology residents. J Med Educ (1969) 1.16
The low-affinity p75 nerve growth factor (NGF) receptor mediates NGF-induced tyrosine phosphorylation. Proc Natl Acad Sci U S A (1991) 1.15
Neurotrophins: the biological paradox of survival factors eliciting apoptosis. Cell Death Differ (1998) 1.14
A prosurvival function for the p75 receptor death domain mediated via the caspase recruitment domain receptor-interacting protein 2. J Neurosci (2001) 1.14
Development of insulin responsiveness of the glucose transporter and the (Na+,K+)-adenosine triphosphatase during in vitro adipocyte differentiation. J Biol Chem (1982) 1.13
Chimeric NGF-EGF receptors define domains responsible for neuronal differentiation. Science (1991) 1.12
Solution structure and dynamics of the bioactive retroviral M domain from Rous sarcoma virus. J Mol Biol (1998) 1.11
Regulation of enzymatic activity by active site fatty acylation. A new role for long chain fatty acid acylation of proteins. J Biol Chem (1994) 1.10
TrkA immunoglobulin-like ligand binding domains inhibit spontaneous activation of the receptor. Mol Cell Biol (2000) 1.10
Ectopic expression of p27Kip1 in oligodendrocyte progenitor cells results in cell-cycle growth arrest. J Neurobiol (1998) 1.10
The uniqueness of being a neurotrophin receptor. Curr Opin Neurobiol (2001) 1.09
Neurotrophins in cell survival/death decisions. Adv Exp Med Biol (1999) 1.08
A potential interaction of p75 and trkA NGF receptors revealed by affinity crosslinking and immunoprecipitation. J Neurosci Res (1995) 1.08
Developmentally regulated expression of the nerve growth factor receptor gene in the periphery and brain. Proc Natl Acad Sci U S A (1987) 1.07
Activation of mitogen-activated protein kinase by membrane-targeted Raf chimeras is independent of raft localization. J Biol Chem (2001) 1.06
Deletion of cytoplasmic sequences of the nerve growth factor receptor leads to loss of high affinity ligand binding. J Biol Chem (1990) 1.06
Difference between blocking and Néel temperatures in the exchange biased Fe3O4/CoO system. Phys Rev Lett (2000) 1.05
DNA polymorphisms for the nerve growth factor receptor gene exclude its role in familial dysautonomia. Mol Biol Med (1986) 1.04
Clinical value of washed-platelet concentrates in patients with non-hemolytic transfusion reactions. Transfusion (1977) 1.04
HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci (1993) 1.04
Nerve growth factor production by lymphocytes. J Immunol (1994) 1.03
lac Operator nucleosomes. 2. lac Nucleosomes can change conformation to strengthen binding by lac repressor. Biochemistry (1980) 1.03
Defective DNA double-strand break repair underlies enhanced tumorigenesis and chromosomal instability in p27-deficient mice with growth factor-induced oligodendrogliomas. Oncogene (2010) 1.02
Identification of a zinc finger protein whose subcellular distribution is regulated by serum and nerve growth factor. Proc Natl Acad Sci U S A (1999) 1.01
Nerve growth factor stimulates the hydrolysis of glycosylphosphatidylinositol in PC-12 cells: a mechanism of protein kinase C regulation. Proc Natl Acad Sci U S A (1989) 1.01
Mechanisms of neurotrophin receptor signalling. Biochem Soc Trans (2006) 1.00
Differential role of the low affinity neurotrophin receptor (p75) in retrograde axonal transport of the neurotrophins. Neuron (1995) 0.99
Association of the Abl tyrosine kinase with the Trk nerve growth factor receptor. J Neurosci Res (2000) 0.98
Acylation and prenylation of proteins. Curr Opin Cell Biol (1990) 0.98
Adenovirus-mediated gene delivery into neuronal precursors of the adult mouse brain. Proc Natl Acad Sci U S A (1996) 0.98
Oligodendrocyte apoptosis mediated by caspase activation. J Neurosci (1999) 0.98
Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A (1988) 0.98